Upcoming Webinars

An Integrated Approach to De-Risking Bispecific Antibody Development

Biotech, Drug Discovery & Development, Life Science, Pharma, Pharma Manufacturing & Supply Chain,
  • November 04, 2026 | 1:00pm EST (NA) / 6:00pm GMT (UK) / 7:00pm CET (EU-Central)
  • 60 min

Upcoming Webinars

Advances in mRNA & LNP technology for in vivo CAR‑T therapy

Biotech, Cell and Gene Therapy, Drug Discovery & Development, Life Science, Pharma,
  • November 05, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

Integrating Spatial Transcriptomics and Proteomics: Unlocking More from Every Tissue Section

Biotech, Drug Discovery & Development, Laboratory Technology, Life Science, Pharma, Preclinical,
  • November 05, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

Detect Clinician Activity Shifts Earlier to Improve Market Readiness

Clinical Trials, Commercialization & HEOR, Drug Discovery & Development, Life Science, Pharma,
  • November 05, 2026 | 12pm EDT / 11am CDT / 9am PDT / 5pm GMT (UK)
  • 60 min

Upcoming Webinars

Pediatric & Adolescent Obesity: Closing the Evidence Gap Through Better Trial Design

Biomarkers, Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Pharma,
  • November 06, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

November 04, 2026

An Integrated Approach to De-Risking Bispecific Antibody Development
Hero - Desktop
November 05, 2026

Advances in mRNA & LNP technology for in vivo CAR‑T therapy
Hero - Desktop
November 05, 2026

Integrating Spatial Transcriptomics and Proteomics: Unlocking More from Every Tissue Section
Hero - Desktop
November 05, 2026

Detect Clinician Activity Shifts Earlier to Improve Market Readiness
Hero - Desktop
November 06, 2026

Pediatric & Adolescent Obesity: Closing the Evidence Gap Through Better Trial Design
Hero - Desktop
November 09, 2026

Advancing Diabetes Clinical Trials Through Integrated Technology and Operational Oversight
Hero - Desktop
November 09, 2026

ESMO 2026: Key Findings for Cancer Care and Drug Development
Hero - Desktop
November 09, 2026

Beyond ctDNA: EVPs and the Future of Early Cancer Detection
Hero - Desktop
November 10, 2026

Lessons Learned in Neuroscience Drug Development: How Biomarker-based, Evidence-driven Decisions Enable Successful Outcomes
Hero - Desktop
November 10, 2026

Apply Emerging Biomarkers to Improve Neurodegenerative Disease Trials
Hero - Desktop
November 11, 2026

Potency Assays for Modern Biologics: Expert Insights and Future Trends
Hero - Desktop
November 11, 2026

Accelerate CQV & Compliance: Why Documentation Quality Drives Operational Readiness
Hero - Desktop
November 12, 2026

FDA Meetings: Engaging Regulators Throughout Cell and Gene Therapy Development
Hero - Desktop
November 12, 2026

Enzyme Therapy Manufacturing: Preserving Activity Through Production
Hero - Desktop
November 12, 2026

Can Objective Brain Measures Improve MDD Trial Decisions?
Hero - Desktop
November 16, 2026

Navigating the Evolving Landscape of Glomerular Disease Clinical Trials
Hero - Desktop